PharmaVoice
APRIL 8, 2025
Five years ago, Michelle Werner received her son’s Duchenne muscular dystrophy diagnosis with fear and desperation. Now, as CEO of Alltrna, she’s finding ways to turn those feelings into a better way of treating rare diseases.
Pharmaceutical Technology
APRIL 8, 2025
Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory conditions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 8, 2025
European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to US tariffs.
Pharmaceutical Technology
APRIL 8, 2025
The European Commission (EC) has granted approval for the extension of indication for Janssen-Cilag Internationals Darzalex SC formulation.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
pharmaphorum
APRIL 8, 2025
AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for giant cell arteritis
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
APRIL 8, 2025
Brainomix has been granted FDA approval for a new feature for its AI-powered stroke imaging software that could unlock wider use in the US.
PharmaTech
APRIL 8, 2025
Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.
pharmaphorum
APRIL 8, 2025
AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for Datroway, their TROP2-directed ADC for breast cancer.
PharmaTech
APRIL 8, 2025
Joe Bobacher of OPW Engineered Systems spoke with Pharmaceutical Technology Group at INTERPHEX 2025 about fluid transfer in controlled environments and the importance of guarding against product loss.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharmaceutical Commerce
APRIL 8, 2025
The conferences opening keynote case study shares ways to elicit change that not only results in business growth and productivity, but a boost in patient connection as well.
PharmaTech
APRIL 8, 2025
Advancement of emerging therapies faces hurdles across all aspects and phases of drug development and manufacturing.
Pharmaceutical Commerce
APRIL 8, 2025
Kevin Hagan, CEO, Pan Foundation, discusses central concerns for patient assistance programs as changes to Medicare and the Inflation Reduction Act take effect.
pharmaphorum
APRIL 8, 2025
The UK government and Wellcome Trust will invest 600m in a Health Data Research Service to unlock the power of NHS patient data for medical research
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Commerce
APRIL 8, 2025
The latest news for pharma industry insiders.
PharmExec
APRIL 8, 2025
Results from the Phase III SPACE trial show that Ajovy significantly reduced monthly migraines in pediatric patients between six and 17 years of age.
Pharmaceutical Commerce
APRIL 8, 2025
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, lays out the ways to begin transitioning a foundation.
PharmExec
APRIL 8, 2025
Results from Phase II studies demonstrated that rilzabrutinib showed clinically meaningful outcomes in patients with warm autoimmune hemolytic anemia and IgG4-related disease.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Commerce
APRIL 8, 2025
How data-driven insights can help pharma companies balance their revenue management and innovation strategiesincluding resource allocation, pricing, and market access.
Pharmaceutical Technology
APRIL 8, 2025
KalVista has licenced the commercialisation rights for sebetralstat, a hereditary angioedema (HAE) treatment, to Kaken in Japan.
Pharmaceutical Commerce
APRIL 8, 2025
Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.
Pharmaceutical Technology
APRIL 8, 2025
Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies alternative antibody isotopes for cancer.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmExec
APRIL 8, 2025
LaShell Robinson, head of global feasibility and trial equity at Takeda, talks about Takeda's aims to expand its efforts globally by adapting strategies to regional needs.
Pharmaceutical Technology
APRIL 8, 2025
The investment is expected to reduce clinical trial set up times.
PharmExec
APRIL 8, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
APRIL 8, 2025
US policy changes to withdraw from the WHO and cut USAID have had clinical repercussions throughout Africa. We explore the impact.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmExec
APRIL 8, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
APRIL 8, 2025
Advanced practice provider (APP) care models allow for health systems to better individualize care for patients, effectively meeting their needs.
PharmExec
APRIL 8, 2025
Amy Hessels, vice president of marketing, Bayer, discusses how its Your Decision campaign tackles misinformation about reproductive health by providing the information to empower women to discuss options with healthcare providers.
Expert insights. Personalized for you.
100 
Let's personalize your content